Sevoflurane administration from extracorporeal membrane oxygenation via the AnaConDa device for a patient with COVID-19: A breakthrough solution for the shortage of intravenous anesthetics.
Heart Lung
; 56: 70-73, 2022.
Article
in English
| MEDLINE | ID: covidwho-1895067
ABSTRACT
One of the major issues encountered during the coronavirus disease 2019 (COVID-19) pandemic has been the shortage of intravenous anesthetics. Moreover, patients undergoing extracorporeal membrane oxygenation (ECMO) need large quantities of intravenous anesthetics for sedation. We report the case of a 52-year-old man who was admitted to our hospital due to acute respiratory distress syndrome by COVID-19 and treated with ECMO. As controlling sedation with intravenous anesthetics was challenging, we attempted to administer inhaled anesthetics via the gas flow of ECMO. We decreased the quantity of intravenous anesthetics and opioids. This method might help overcome the shortage of intravenous anesthetics.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Extracorporeal Membrane Oxygenation
/
Boidae
/
COVID-19
Type of study:
Case report
Topics:
Vaccines
Limits:
Animals
/
Humans
/
Male
/
Middle aged
Language:
English
Journal:
Heart Lung
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS